Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19
- PMID: 32738483
- PMCID: PMC7388815
- DOI: 10.1016/j.ijid.2020.07.055
Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19
Comment in
-
A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19.Int J Infect Dis. 2020 Oct;99:138-139. doi: 10.1016/j.ijid.2020.07.059. Epub 2020 Jul 31. Int J Infect Dis. 2020. PMID: 32745629 Free PMC article. No abstract available.
Comment on
-
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2. Int J Infect Dis. 2020. PMID: 32623082 Free PMC article.
References
-
- FDA . 2020. Letter revoking EUA for chloroquine phosphate and hydroxychloroquine sulfate. Available from: https://www.fda.gov/media/138945/download.
-
- Henry Ford Health System . Henry Ford Health System Study Shows; 2020. Treatment with hydroxychloroquine cut death rate significantly in COVID-19 patients. Available from: https://www.henryford.com/news/2020/07/hydro-treatment-study.
-
- Horby P., Lim W.S., Emberson J., Mafham M., Bell J., Linsell L. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv. 2020 doi: 10.1101/2020.06.22.20137273. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources